| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALKBH1
|
alkB, alkylation repair homolog 1 (E. coli)
|
|
ANXA1
|
annexin A1
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
AR
|
androgen receptor
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
ATF1
|
activating transcription factor 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
BACH1
|
BTB and CNC homology 1, basic leucine zipper transcription factor 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BID
|
BH3 interacting domain death agonist
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CCNB1IP1
|
cyclin B1 interacting protein 1, E3 ubiquitin protein ligase
|
|
CCND1
|
cyclin D1
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CERK
|
ceramide kinase
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CSNK1D
|
casein kinase 1, delta
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DCAKD
|
dephospho-CoA kinase domain containing
|
|
DHTKD1
|
dehydrogenase E1 and transketolase domain containing 1
|
|
E2F1
|
E2F transcription factor 1
|
|
EDAR
|
ectodysplasin A receptor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EP300
|
E1A binding protein p300
|
|
ERAL1
|
Era-like 12S mitochondrial rRNA chaperone 1
|
|
ESR1
|
estrogen receptor 1
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAU
|
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed
|
|
FER
|
fer (fps/fes related) tyrosine kinase
|
|
FILIP1
|
filamin A interacting protein 1
|
|
FOXO1
|
forkhead box O1
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GDI1
|
GDP dissociation inhibitor 1
|
|
GRIK1-AS2
|
GRIK1 antisense RNA 2
|
|
GRN
|
granulin
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
HDAC1
|
histone deacetylase 1
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
IMPA1
|
inositol(myo)-1(or 4)-monophosphatase 1
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITPKC
|
inositol-trisphosphate 3-kinase C
|
|
JAK1
|
Janus kinase 1
|
|
JAKMIP1
|
janus kinase and microtubule interacting protein 1
|
|
JUN
|
jun proto-oncogene
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LGALS13
|
lectin, galactoside-binding, soluble, 13
|
|
MAP3K13
|
mitogen-activated protein kinase kinase kinase 13
|
|
MAP3K7CL
|
MAP3K7 C-terminal like
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAX
|
MYC associated factor X
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCBP2
|
MYC binding protein 2, E3 ubiquitin protein ligase
|
|
MYT1
|
myelin transcription factor 1
|
|
NAB1
|
NGFI-A binding protein 1 (EGR1 binding protein 1)
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NF1
|
neurofibromin 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOXA1
|
NADPH oxidase activator 1
|
|
NUP85
|
nucleoporin 85kDa
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PHB
|
prohibitin
|
|
PIAS1
|
protein inhibitor of activated STAT, 1
|
|
PIGR
|
polymeric immunoglobulin receptor
|
|
PIK3R2
|
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
|
|
PKIA
|
protein kinase (cAMP-dependent, catalytic) inhibitor alpha
|
|
PLK1
|
polo-like kinase 1
|
|
PLK3
|
polo-like kinase 3
|
|
PML
|
promyelocytic leukemia
|
|
PTEN
|
phosphatase and tensin homolog
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RAD54L
|
RAD54-like (S. cerevisiae)
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RALGAPA1
|
Ral GTPase activating protein, alpha subunit 1 (catalytic)
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RASGEF1A
|
RasGEF domain family, member 1A
|
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated)
|
|
RB1
|
retinoblastoma 1
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHO
|
rhodopsin
|
|
RPP38
|
ribonuclease P/MRP 38kDa subunit
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
SELK
|
selenoprotein K
|
|
SIRT1
|
sirtuin 1
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD6
|
SMAD family member 6
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMEK1
|
SMEK homolog 1, suppressor of mek1 (Dictyostelium)
|
|
SMEK2
|
SMEK homolog 2, suppressor of mek1 (Dictyostelium)
|
|
SP1
|
Sp1 transcription factor
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STK11
|
serine/threonine kinase 11
|
|
TAB1
|
TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TP53
|
tumor protein p53
|
|
TPR
|
translocated promoter region, nuclear basket protein
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
UBE2F
|
ubiquitin-conjugating enzyme E2F (putative)
|
|
USP15
|
ubiquitin specific peptidase 15
|
|
USP16
|
ubiquitin specific peptidase 16
|
|
USP21
|
ubiquitin specific peptidase 21
|
|
USP38
|
ubiquitin specific peptidase 38
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
ZMIZ1
|
zinc finger, MIZ-type containing 1
|
|
ZMYND8
|
zinc finger, MYND-type containing 8
|
|
ZNF655
|
zinc finger protein 655
|
